DorightLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

DorightLtd şirketinin toplam hissedar öz sermayesi CN¥742.5M ve toplam borcu CN¥4.2M olup, bu da borç-öz sermaye oranını 0.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥1.1B ve CN¥310.5M dir. DorightLtd 'in FAVÖK'ü CN¥109.3M faiz karşılama oranı -15.9 dur. Şirketin CN¥167.1M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

0.6%

Borç/özkaynak oranı

CN¥4.19m

Borç

Faiz karşılama oranı	-15.9x
Nakit	CN¥167.10m
Eşitlik	CN¥742.50m
Toplam yükümlülükler	CN¥310.51m
Toplam varlıklar	CN¥1.05b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Investors Shouldn't Be Too Comfortable With DorightLtd's (SZSE:300950) Earnings

Oct 31

Doright Co.,Ltd.'s (SZSE:300950) Share Price Could Signal Some Risk

Sep 27

Some Investors May Be Worried About DorightLtd's (SZSE:300950) Returns On Capital

Jul 18

DorightLtd (SZSE:300950) Is Increasing Its Dividend To CN¥0.15

Jun 07

Doright Co.,Ltd. (SZSE:300950) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected

May 06

We Think That There Are More Issues For DorightLtd (SZSE:300950) Than Just Sluggish Earnings

Apr 30

Doright Co.,Ltd. (SZSE:300950) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Mar 04

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 300950 'nin kısa vadeli varlıkları ( CN¥609.7M ) kısa vadeli yükümlülüklerini ( CN¥284.3M ) aşıyor.

Uzun Vadeli Yükümlülükler: 300950 şirketinin kısa vadeli varlıkları ( CN¥609.7M ) uzun vadeli yükümlülüklerini ( CN¥26.2M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 300950 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 300950 'nin borç/öz sermaye oranı son 5 yılda 2.9% seviyesinden 0.6% seviyesine düştü.

Borç Kapsamı: 300950 'nin borcu işletme nakit akışı ( 1180% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 300950 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

DorightLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Investors Shouldn't Be Too Comfortable With DorightLtd's (SZSE:300950) Earnings

Third quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.041 in 3Q 2023)

Investor sentiment deteriorates as stock falls 15%

Doright Co.,Ltd. Approves the Election of the Board of Directors

New minor risk - Share price stability

Doright Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024

Investor sentiment improves as stock rises 30%

Doright Co.,Ltd.'s (SZSE:300950) Share Price Could Signal Some Risk

Second quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.074 in 2Q 2023)

Some Investors May Be Worried About DorightLtd's (SZSE:300950) Returns On Capital

Doright Co.,Ltd. to Report First Half, 2024 Results on Aug 29, 2024

DorightLtd (SZSE:300950) Is Increasing Its Dividend To CN¥0.15

Dividend increased to CN¥0.15

Doright Co.,Ltd. Implements Final Profit Distribution Plan of A Shares, Payable on 11 June 2024

Doright Co.,Ltd. (SZSE:300950) Stock Rockets 36% As Investors Are Less Pessimistic Than Expected

We Think That There Are More Issues For DorightLtd (SZSE:300950) Than Just Sluggish Earnings

Investor sentiment improves as stock rises 31%

Doright Co.,Ltd., Annual General Meeting, May 22, 2024

First quarter 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.14 in 1Q 2023)

Investor sentiment deteriorates as stock falls 21%

Doright Co.,Ltd. to Report Q1, 2024 Results on Apr 24, 2024

Doright Co.,Ltd. (SZSE:300950) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Investor sentiment improves as stock rises 17%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 17%

Doright Co.,Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024

Third quarter 2023 earnings released: EPS: CN¥0.041 (vs CN¥0.18 in 3Q 2022)

Doright Co.,Ltd. to Report Q3, 2023 Results on Oct 28, 2023

Second quarter 2023 earnings released: EPS: CN¥0.074 (vs CN¥0.12 in 2Q 2022)

Now 21% undervalued

Doright Co.,Ltd. Approves Cash Dividend for the Year 2022, Payable on 30 May 2023

Doright Co.,Ltd. Approves Cash Dividend for the Year 2022

Investor sentiment improves as stock rises 15%

First quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.036 in 1Q 2022)

Investor sentiment deteriorates as stock falls 17%

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.046 in 3Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.061 in 2Q 2021)

Investor sentiment improved over the past week

Doright Co.,Ltd. Announces Final Profit Distribution Plan for 2021, Payable on 08 June 2022

Doright Co.,Ltd. Approves Cash Dividend for the Year 2021

First quarter 2022 earnings released: EPS: CN¥0.054 (vs CN¥0.10 in 1Q 2021)

High number of new and inexperienced directors

Doright Co.,Ltd. Proposes Cash Dividend for 2021

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.069 (vs CN¥0.073 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.092 (vs CN¥0.32 in 2Q 2020)

Investor sentiment deteriorated over the past week

Doright Co.,Ltd. Announces Final Cash Dividend for 2020, Payable on 01 June 2021

Full year 2020 earnings released: EPS CN¥0.82 (vs CN¥0.83 in FY 2019)

Investor sentiment deteriorated over the past week

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin